IL11 and cancer: Transcription factors such as STAT3 and NF-κB enhance IL11 transcription under inflammatory conditions, while cooperation with ERK signaling regulates processes including cell cycle progression, differentiation, and immune evasion in pathologies such as cancer and tissue injury (56–58).